Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0001 Transporter Info | ||||
| Gene Name | ABCC1 | ||||
| Transporter Name | Multidrug resistance-associated protein 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Ivermectin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 6321424 | ||||
| Docking Score | -10.408 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C48H74O14 | ||||
| Molecular Weight | 875.1 | ||||
| Canonical SMILES |
CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)C
|
||||
| InChI |
InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1
|
||||
| InChIKey | AZSNMRSAGSSBNP-XPNPUAGNSA-N | ||||
| Pharmaceutical Properties | Xlogp | 4.1 | Rotatable Bond Count | 8 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 14 | ||
| Xenobiotic Name | Idarubicin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 42890 | ||||
| Docking Score | -9.624 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C26H27NO9 | ||||
| Molecular Weight | 497.5 | ||||
| Canonical SMILES |
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O
|
||||
| InChI |
InChI=1S/C26H27NO9/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31/h3-6,10,15-17,21,29,32-34H,7-9,27H2,1-2H3/t10-,15-,16-,17-,21+,26-/m0/s1
|
||||
| InChIKey | XDXDZDZNSLXDNA-TZNDIEGXSA-N | ||||
| Pharmaceutical Properties | Xlogp | 1.9 | Rotatable Bond Count | 3 | |
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 10 | ||
| Xenobiotic Name | Curcumin Drug Info | ||||
| Xenobiotic Type | Drug in Phase 3 Trial | ||||
| MOA | Inhibition | ||||
| PubChem CID | 969516 | ||||
| Docking Score | -9.601 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C21H20O6 | ||||
| Molecular Weight | 368.4 | ||||
| Canonical SMILES |
COC1=C(C=CC(=C1)/C=C/C(=O)CC(=O)/C=C/C2=CC(=C(C=C2)O)OC)O
|
||||
| InChI |
InChI=1S/C21H20O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-12,24-25H,13H2,1-2H3/b7-3+,8-4+
|
||||
| InChIKey | VFLDPWHFBUODDF-FCXRPNKRSA-N | ||||
| Pharmaceutical Properties | Xlogp | 3.2 | Rotatable Bond Count | 8 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 6 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.